ACTION: Notification; declaratory order; extension of compliance date.

Similar documents
April 30, By Electronic Mail

SUMMARY: The Food and Drug Administration (FDA) is requesting public input on updated

Highly Concentrated Caffeine in Dietary Supplements; Guidance for Industry; Availability

Agency Information Collection Activities; Submission for Office of Management and

Listing of Color Additives Exempt from Certification; Synthetic Iron Oxide

Agency Information Collection Activities; Submission for Office of Management and Budget

Three-Month Extension of Certain Tobacco Product Compliance Deadlines Related to the

Flavored Milk; Petition to Amend the Standard of Identity for Milk and 17 Additional Dairy

Food Labeling: Revision of the Nutrition and Supplement Facts Labels and Serving Sizes of

Use of Light, Mild, Low, or Similar Descriptors in the Label, Labeling, or Advertising of Tobacco Products

Food Additives Permitted for Direct Addition to Food for Human Consumption; Vitamin D 2

Generic Drug User Fee Amendments of 2012; Regulatory Science Initiatives; Public Hearing;

SUMMARY: The Food and Drug Administration (FDA or we) is amending the color additive

Fruit Juice and Vegetable Juice as Color Additives in Food: Guidance for Industry

Food Additives Permitted for Direct Addition to Food for Human Consumption; Acacia (Gum

Withdrawal of Proposed Rule on Supplemental Applications Proposing Labeling Changes for

ANDA Arthur P. Bedrosian, President Armenpharm, Ltd. 49 South Ridge Road P.O. Box D1400 Pomona, NY December 3, 2015

Opioid Policy Steering Committee: Prescribing Intervention--Exploring a Strategy for

Indirect Food Additives: Adhesives and Components of Coatings and Paper and Paperboard Components

May 7, Dear Mr. Landa:

Agency Information Collection Activities; Submission for Office of Management and

Listing of Color Additives Exempt From Certification; Spirulina Extract

Food Labeling: Health Claims; Dietary Saturated Fat and Cholesterol and Risk of Coronary

UNITED STATES DEPARTMENT OF HEALTH AND HUMAN SERVICES FOOD AND DRUG ADMINISTRATION

SUMMARY: The Food and Drug Administration (FDA, the Agency, or we) is proposing to

Patient-Focused Drug Development Public Meeting on Chagas Disease

Controlling the Progression of Myopia: Contact Lenses and Future Medical Devices; Public

Edible Fats and Oils Regulatory Update. National Institute of Oilseed Products March 16-18, 2014 San Antonio, TX

SUMMARY: The Food and Drug Administration (FDA, the Agency, or we) is amending its

DATES: This rule is effective December 8, See section X for further information on the

Teva Pharmaceuticals USA Attention: Scott D. Tomsky Vice President, US Generics Regulatory Affairs 425 Privet Road Horsham, PA 19044

June 9, U.S. Food and Drug Administration Division of Dockets Management, HFA Fishers Lane, Room 1061 Rockville, MD 20852

February 10, Division of Dockets Management HFA-305 Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, MD 20852

ANDA Submissions Refuse to Receive for Lack of Proper Justification of Impurity Limits Guidance for Industry

NDI: LOOKING BACK & AHEAD

Food Additives Program

The Marketing of a Food Ingredient Understanding a System that has Worked for 105 Years

The Food and Drug Administration's Approach to Evaluating Nicotine Replacement Therapies;

FDA s Food Additives Program

December 4, 2017 VIA ELECTRONIC SUBMISSION

Safety Evaluation for Substances Directly Added to Food

Qualification of Drivers; Exemption Applications; Epilepsy and Seizure Disorders; AGENCY: Federal Motor Carrier Safety Administration (FMCSA), DOT.

Schedules of Controlled Substances: Placement in Schedule V of Certain FDA- Approved Drugs Containing Cannabidiol; Corresponding Change to Permit

RE: Permits under the Arizona Pharmacy Act should not be required for dietary supplements

Responsibilities of Laser Light Show Projector Manufacturers, Dealers, and Distributors; Final Guidance for Industry and FDA.

Clinical Chemistry and Clinical Toxicology Devices Panel of the Medical Devices Advisory

memorandum Venable s FDA Practice Group FDA Publishes Draft Guidance on New Dietary Ingredients ( NDIs )

Dietary Supplement Health and Education Act of 1994 Public Law rd Congress

Washington Update PTNPA Day in Washington Martin J. Hahn, Partner Hogan Lovells US, LLP. May 10, 2018

Effective and Compliance Dates Applicable to Retailers, Manufacturers, Importers, and Distributors of Newly Deemed Tobacco Products

Rock Solid Nutrition, LLC 12/22/16

Proposed Data Collection Submitted for Public Comment and. AGENCY: Centers for Disease Control and Prevention (CDC),

Guidance for Industry DRAFT GUIDANCE. This guidance document is being distributed for comment purposes only.

Guidance for Industry and FDA Staff

October 31, Draft Guidance for Industry, Frequently Asked Questions About Medical Foods; Second Edition

Taylor C. Wallace, PhD, CFS, FACN, March 22, 2018

Food Labeling: Revision of the Nutrition and Supplement Facts Labels; Supplemental Proposed

The proposed rule is significant, and the requirements and exceptions are complex. Key provisions of the proposal are described below.

Distillers Grains Opportunities and Challenges

Federal Register / Vol. 58, No. 3 / Wednesday, January 6, 1993 / Rules and Regulations 2431

Infant Formula: The Addition of Minimum and Maximum Levels of Selenium to Infant Formula

34650 Federal Register / Vol. 80, No. 116 / Wednesday, June 17, 2015 / Notices

2014 FDA/JIFSAN Food & Nutrition Webinar

Guidance for Industry

Centers for Disease Control and Prevention. Proposed Revised Vaccine Information Materials for MMR

Centers for Disease Control and Prevention. Final Revised Vaccine Information Materials for MMR

Inter-Agency Overlap and Jurisdictional Boundaries

Raritan Pharmaceuticals, Inc. 6/20/17

Re: National Bioengineered Food Disclosure Standard; Proposed Rule; Request for Comments, 83 Fed. Reg (May 4, 2018), Docket No.

Client Alert. FDA Draft Guidance Broadens New Dietary Ingredient Definition and Extends Notification Requirements 1

Re: Docket No. FDA-2011-N-0922; Current Good Manufacturing Practice and Hazard Analysis and Risk-Based Preventive Controls for Food for Animals

FDA Food Contact Fundamentals

DEPARTMENT OF TRANSPORTATION. National Highway Traffic Safety Administration. [Docket Number: NHTSA ]

TSDR Pharmacy Inc. dba brandmd Skin Care 11/9/17

Reishi D. International, Inc. 2/6/18

Nestle Infant Nutrition 10/31/14

Subpart A General Provisions

June 9, PET FOOD INSTITUTE 2025 M Street, NW, Suite 800 Washington, DC M Street NW Suite 800 Washington, DC Page 1 of 6

FDLI s Enforcement, Litigation, and Compliance Conference. Center for Tobacco Products Office of Compliance and Enforcement 2017 Update

Availability of FSIS Compliance Guidelines for Allergens and. Ingredients of Public Health Concern: Identification, Prevention

The Basics of the U.S. FDA s Regulation of Materials Used in Food Packaging Applications

STATEMENT OF JOSHUA M. SHARFSTEIN, M.D. PRINCIPAL DEPUTY COMMISSIONER U.S. FOOD AND DRUG ADMINISTRATION DEPARTMENT OF HEALTH AND HUMAN SERVICES

Purpose of this Document

Schedules of Controlled Substances: Placement of Furanyl fentanyl, 4- Fluoroisobutyryl fentanyl, Acryl fentanyl, Tetrahydrofuranyl fentanyl, and

Class II Special Controls Guidance Document: Intraoral Devices for Snoring and/or Obstructive Sleep Apnea; Guidance for Industry and FDA

Food Labeling Enforcement and Compliance Priorities in the Current Environment

October 11, Dockets Management Staff (HFA-305) Food and Drug Administration 5630 Fishers Lane, Rm Rockville, MD 20852

SUMMARY: This document announces the renewal of 17 substances on the National List of

Guidance for Industry

Over-the-Counter Pediatric Liquid Drug Products Containing Acetaminophen

Draft Guidance for Industry and FDA Staff

Guidance for Industry: Sanitary Transportation of Food

Establishment of a New Drug Code for Marihuana Extract. AGENCY: Drug Enforcement Administration, Department of Justice.

National Vaccine Injury Compensation Program: Adding the Category of Vaccines. AGENCY: Health Resources and Services Administration (HRSA), HHS.

Intent to Consider the Appropriate Classification of Hyaluronic Acid Intra-articular Products

Subtitle E--National Bioengineered Food Disclosure Standard

(Cochineal Extract and Carmine: Declaration by Name on the Label of All Foods and Cosmetic Products That Contain These Color Additives)

July 3, Re: Proposed Rule: National Bioengineered Food Disclosure Standard. 83 FR (May 4, 2018). Docket No. AMS-TM

FDA REGULATION OF DIETARY SUPPLEMENTS AND FOODS

Transcription:

This document is scheduled to be published in the Federal Register on 05/21/2018 and available online at https://federalregister.gov/d/2018-10714, and on FDsys.gov DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration 21 CFR Part 172 [Docket No. FDA-2013-N-1317] Final Determination Regarding Partially Hydrogenated Oils AGENCY: Food and Drug Administration, HHS. ACTION: Notification; declaratory order; extension of compliance date. SUMMARY: Based on the available scientific evidence and the findings of expert scientific panels, the Food and Drug Administration (FDA or we) made a final determination that there is no longer a consensus among qualified experts that partially hydrogenated oils (PHOs), which are the primary dietary source of industrially produced trans fatty acids (IP-TFA), are generally recognized as safe (GRAS) for any use in human food. In a declaratory order announcing our final determination, we set a compliance date of June 18, 2018. We are now extending the compliance date for certain uses of PHOs. DATES: Compliance dates: See sections II and III of this document. FOR FURTHER INFORMATION CONTACT: Ellen Anderson, Center for Food Safety and Applied Nutrition (HFS-265), Food and Drug Administration, 5001 Campus Dr., College Park, MD 20740, 240-402-1309, email: ellen.anderson@fda.hhs.gov. SUPPLEMENTARY INFORMATION: I. Background In the Federal Register of June 17, 2015 (80 FR 34650), we issued a final determination that there is no longer a consensus among qualified experts that PHOs are GRAS for any use in human food. Because PHOs are the primary dietary source of IP-TFA, FDA s evaluation of the

GRAS status of PHOs centered on the trans fatty acid component of these fats and oils. We based our determination on available scientific evidence and the findings of expert scientific panels establishing the health risks associated with the consumption of trans fat. FDA s determination identified significant human health risks, namely an increased risk of coronary heart disease, associated with the consumption of trans fat (78 FR 67169 at 67172; 80 FR 34650 at 34659). The order established a 3-year compliance date, to June 18, 2018, to allow time for food manufacturers using PHOs to identify suitable replacement ingredients for PHOs and to reformulate and modify labeling of affected products. The 3-year compliance date was also intended to allow time for submission and review and, if applicable requirements were met, approval of food additive petitions for uses of PHOs for which industry or other interested individuals believe that safe conditions of use may be prescribed. Finally, this compliance date was also intended to give manufacturers time to exhaust existing inventories and give distributors and retailers time to distribute products with PHOs (80 FR 34650 at 34669). We based the compliance date on the information available, including comments on the proposed order (80 FR 34650 at 34668 to 34669). In the 2015 final order, we stated that food that is adulterated may be subject to seizure and distributors, manufacturers, and other parties responsible for such food may be subject to injunction. We also reminded distributors and other members of the food industry that they have an obligation to ensure that the food they manufacture, distribute, sell, or otherwise market complies with the Federal Food, Drug, and Cosmetic Act (FD&C Act) (80 FR 34650 at 34655). In the Federal Register of October 28, 2015 (80 FR 65978), we published a document announcing that we had filed a food additive petition submitted by the Grocery Manufacturers

Association (GMA) seeking approval for certain uses of PHOs in or on select foods. We initially filed the food additive petition on October 1, 2015. GMA subsequently amended their food additive petition, and it was re-filed on March 7, 2017. The amended food additive petition requested that the food additive regulations be amended to provide for the safe use of PHOs in certain food applications. Elsewhere in this issue of the Federal Register, we have published a document announcing our denial of this food additive petition. For purposes of this document extending the compliance date for certain uses of PHOs, we refer to the specified uses of PHOs in GMA s food additive petition as the petitioned uses and all other uses of PHOs not authorized by FDA as non-petitioned uses. We refer to manufacturing in this document as making food from one or more ingredients, or synthesizing, preparing, treating, modifying or manipulating food, including food crops or ingredients. See 21 CFR 1.227. On March 23, 2018, the Consolidated Appropriations Act, 2018, (Pub. L. 115-141) was enacted into law. Section 738 of the Consolidated Appropriations Act, 2018, provided that no PHOs, as defined in our declaratory order, shall be deemed unsafe within the meaning of section 409(a) of the FD&C Act (21 U.S.C. 348(a)) and no food that is introduced or delivered for introduction into interstate commerce that bears or contains a partially hydrogenated oil shall be deemed adulterated under sections 402(a)(1) or (a)(2)(c)(i) of the FD&C Act (21 U.S.C. 342(a)(1) or (a)(2)(c)(i)) by virtue of bearing or containing a partially hydrogenated oil, until June 18, 2018. II. Extension of the Compliance Date for Certain Uses We have been informed by a number of trade associations representing many segments of the food industry that they have replaced the PHO uses that are not covered by the food additive

petition (the non-petitioned uses) and thus will be able to stop using PHOs by the June 18, 2018, compliance date (Ref. 1). However, the trade associations also have informed us that, due to shelf lives ranging from 3 to 24 months, a variety of products containing non-petitioned uses of PHOs will be in distribution on, and for some time after, the compliance date in the final order (Ref. 1). In addition, the trade associations have informed us that, if we deny the food additive petition, they will need additional time beyond June 18, 2018, to remove and replace the petitioned uses and deplete the product in distribution (Refs. 1 and 2). FDA has considered these requests as well as the health benefits of removing the uses of PHOs in food manufacturing and is revising the compliance date for certain uses. A. Non-Petitioned Uses Foods manufactured after June 18, 2018 with non-petitioned uses of PHOs may be subject to enforcement action by FDA. Based on the recent industry information, FDA understands additional time is needed for products manufactured (domestically and internationally) before June 18, 2018, to work their way through distribution. Therefore, we are extending the compliance date of food products that were manufactured before June 18, 2018, with non-petitioned uses of PHO. The new compliance date for these products is January 1, 2020. After January 1, 2020, such foods may be subject to enforcement action by FDA. FDA believes an 18-month extension is appropriate given the range of shelf lives brought to our attention and the 3-year original compliance date. B. Petitioned Uses In light of our denial of GMA s food additive petition, we acknowledge that the food industry needs additional time to identify suitable replacement substances for the petitioned uses of PHOs and that the food industry may not have done so for the petitioned uses while the

petition was under our review. Industry has indicated that 12 months could be a reasonable timeframe for reformulation activities (Ref 1). Therefore, we are extending the compliance date to June 18, 2019, for the manufacturing of food with the petitioned uses of PHOs. Food manufactured with the petitioned uses after June 18, 2019, may be subject to enforcement action by FDA. The petitioned uses are as follows: PHO, or a blend of PHOs, used as a solvent or carrier, or a component thereof, for flavoring agents, flavor enhancers, and coloring agents intended for food use, provided the PHOs in the solvent or carrier contribute no more than 150 parts per million (ppm) (150 milligrams per kilogram (mg/kg)) IP-TFA to the finished food as consumed; PHO, or a blend of PHOs, used as a processing aid, or a component thereof, provided the PHOs in the processing aid contribute no more than 50 ppm (50 mg/kg) IP-TFA to the finished food as consumed; PHO, or a blend of PHOs, used as a pan release agent for baked goods at levels up to 0.2 grams/100 grams (0.2 g/100 g) in pan release spray oils, provided the PHO contributes no more than 0.14 g IP-TFA/100 g spray oil. The petitioned uses excluded dietary supplements. The physical and technical effects of the petitioned uses of PHOs were specified as: release agents, either alone or in combination with other components ( 170.3(o)(18) (21 CFR 170.3(o)(18))); processing aids or components thereof ( 170.3(o)(24)); and as solvents, carriers, and vehicles for fat soluble coloring agents, flavoring agents, and flavor enhancers ( 170.3(o)(27)). In addition, for food manufactured with the petitioned uses before June 18, 2019, we are extending the compliance date to January 1, 2021. This time frame will allow manufacturers,

distributors, and retailers to exhaust product inventory of foods made with the petitioned uses before the manufacturing compliance date. All foods containing unauthorized uses of PHOs after January 1, 2021, may be subject to FDA enforcement action. III. Compliance Dates For convenience, we are summarizing the extended compliance dates as follows: Non-Petitioned Uses Product Uses Original Compliance Date Extended Compliance Date Manufacturing of food with nonpetitioned June 18, 2018 Not Extended uses of PHOs Foods manufactured with nonpetitioned June 18, 2018 January 1, 2020 uses of PHOs before June 18, 2018 Petitioned Uses * Product Uses Original Compliance Date Extended Compliance Date Manufacturing of food with the June 18, 2018 June 18, 2019 petitioned uses of PHOs Foods manufactured with the petitioned uses of PHOs before June 18, 2019 June 18, 2018 January 1, 2021 * Petitioned uses exclude use in dietary supplements and are limited to: PHO, or a blend of PHOs, used as a pan release agent for baked goods at levels up to 0.2 grams/100 grams (0.2 g/100 g) in pan release spray oils, provided the PHO contributes no more than 0.14 g IP-TFA/100 g spray oil; PHO, or a blend of PHOs, used as a solvent or carrier, or a component thereof, as defined in 170.3(o)(27), for flavoring agents, flavor enhancers, and coloring agents intended for food use, provided the PHOs in the solvent or carrier contribute no more than 150 parts per million (ppm) (150 milligrams per kilogram (mg/kg)) IP-TFA to the finished food as consumed; and PHO, or a blend of PHOs, used as a processing aid, or a component thereof, as defined in 170.3(o)(24) and 21 CFR 101.100(a)(3)(ii), provided the PHOs in the processing aid contribute no more than 50 ppm (50 mg/kg) IP-TFA to the finished food as consumed. IV. References The following references are on display in the Dockets Management Staff (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852, and are available for viewing by interested persons between 9 a.m. and 4 p.m., Monday through Friday.

1. Letter from the American Bakers Association, et al., to Dr. Scott Gottlieb, Commissioner, Food and Drug Administration (April 30, 2018) (sent by electronic mail). 2. Letter from Leon H. Bruner, DVM, Ph.D., Senior Vice President, Science and Regulatory Affairs and Chief Science Officer, Grocery Manufacturers Association, to Dr. Scott Gottlieb, Commissioner, Food and Drug Administration (April 27, 2018). Dated: May 15, 2018. Leslie Kux, Associate Commissioner for Policy. BILLING CODE 4164-01-P [FR Doc. 2018-10714 Filed: 5/18/2018 8:45 am; Publication Date: 5/21/2018]